Day: April 14, 2022

Detroit, April 14, 2022 (GLOBE NEWSWIRE) — DETROIT, April 14, 2022 – DTE Energy (NYSE:DTE) will announce its first quarter 2022 earnings before the market opens Thursday, April 28, 2022. The company will conduct a conference call to discuss earnings results at 9 a.m. ET the same day. Investors, the news media and the public may listen to a live internet broadcast of the call at dteenergy.com/investors. The telephone dial-in number in the U.S. and Canada toll free is: (888) 510-2008 or international toll: (646) 960-0306. The passcode is 4987588. The webcast will be archived on the DTE Energy website at dteenergy.com/investors. About DTE Energy  DTE Energy (NYSE: DTE) is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services nationwide. Its operating units...

BEVERLY, Mass., April 14, 2022 (GLOBE NEWSWIRE) — ATN International, Inc. (“ATN” or the “Company”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, announced today that it will release first quarter 2022 results on Wednesday, April 27, 2022, after market close. The Company will host a conference call to discuss its results at 10:30 a.m. ET on Thursday, April 28, 2022. Dial-in information for the conference call is as follows:Call Date: Thursday, April 28, 2022Call Time: 10:30 a.m. ETCall Dial-ins: (877) 734-4582 (US/Canada), (678) 905-9376 (International)Conference ID: 7884416 Investors also can listen to a live audio webcast of the conference call and view the presentation slides by visiting the “Events & Presentations” section of the company’s Investor Relations...

An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 14, 2022 (GLOBE NEWSWIRE) — Breaking news from  SPYR Inc. (OTCQB: SPYR), a technology company whose subsidiary, Applied Magix, Inc., develops and resells Apple® ecosystem compatible products in the growing multibillion-dollar IoT smart home and connected car markets is interesting for several reasons. Let’s start with the headline: “SPYR Technologies’ Applied Magix Considers MVNO Business” For starters, investors at this strata of the market aren’t often privy to thinking-out-loud press releases like this. And while the staff at The Emerging Market Report greatly prefers firm items like signed agreements versus say LOI’s or contemplated market moves, transparency such as the release from the team at SPYR, who has a history of doing things differently can be revealing. First...

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that the company will participate in the public-private partnership Oncode-PACT, which will be supported by the National Growth Fund, an initiative of the Dutch Ministry of Economic Affairs and Climate Policy and the Ministry of Finance. The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer drugs. This has just been announced during the press conference by Jeroen Dijsselbloem, chairman of the National Growth Fund Committee. With this investment, Oncode-PACT will develop valuable drug candidates faster and cheaper and thus bring them to patients sooner. This will improve the quality of life...

Primary Mortgage Market Survey® U.S. weekly average mortgage rates as of April 14, 2022.MCLEAN, Va., April 14, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 5.00 percent. “This week, mortgage rates averaged five percent for the first time in over a decade,” said Sam Khater, Freddie Mac’s Chief Economist. “As Americans contend with historically high inflation, the combination of rising mortgage rates, elevated home prices and tight inventory are making the pursuit of homeownership the most expensive in a generation.” News Facts30-year fixed-rate mortgage averaged 5.00 percent with an average 0.8 point as of April 14, 2022, up from last week when it averaged 4.72 percent. A year ago at this...

London, April 14, 2022 A 25-ton combine harvester advancing through a wheat field is an impressive spectacle to behold. This sight is the culmination of an extensive research and development process that blends tried and tested design and engineering acumen with rigorous testing. Now, thanks to an ever-evolving tech landscape, much is changing in the R&D space. CNH Industrial (NYSE: CNHI / MI: CNHI) is using virtual technologies as part of an innovative approach to equipment development. This provides swift and scaled up solutions that improve customer productivity, while further enhancing their overall user experience. It also spearheads a safer, more sustainable approach to product evaluation using computer simulated environments, virtual cabs and modeling techniques. Head over to bit.ly/BreakingNewGround-VirtualTesting for the...

This initiative is one of a number of moves SFIO is making to champion transparency and maximize shareholder value across its community. NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) — Starfleet Innotech Inc. (OTC Pink: SFIO), a global investment holding company, is pleased to announce that the company is reducing its current authorized share count by 50% from five billion to 2.5 billion.  “We believe this reduction leaves enough shares in reserve for us to continue our capital raising efforts, while also minimizing dilution among our shareholders,” said CEO Jeths Lacson.  SFIO is also announcing the creation of a new class of preferred shares pending processing on NVSOS, to be used for future acquisitions, as well as for onboarding new officers and key partners. The Series B Preferred Shares consist of 310 million shares—largely converted...

April events to highlight Longeveron’s commitment to developing cell therapeutics for chronic aging related diseases. MIAMI, April 14, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today its Chief Science Officer, Co-Founder, and Chairman, Joshua Hare, M.D., F.A.C.C., F.A.H.A. will be presenting at the Longevity Leaders World Congress in April. Also this month, Longeveron Director of Medical Affairs Kevin N. Ramdas, M.D. M.P.H. will present at the upcoming 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) as well as the 3rd Annual Latinos & Alzheimer’s Symposium hosted by the Alzheimer’s Association,...